These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19946126)

  • 21. Age-related pregnancy results and further examination of bitches after aglepristone treatment of pyometra.
    Jurka P; Max A; Hawryńska K; Snochowski M
    Reprod Domest Anim; 2010 Jun; 45(3):525-9. PubMed ID: 19055567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical treatment for pyometra in dogs.
    Fieni F; Topie E; Gogny A
    Reprod Domest Anim; 2014 Jun; 49 Suppl 2():28-32. PubMed ID: 24947858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mid-gestation pregnancy termination by the progesterone antagonist aglepristone in queens.
    Georgiev P; Wehrend A
    Theriogenology; 2006 Apr; 65(7):1401-6. PubMed ID: 16198402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, ultrasonography and haematology of aglepristone-induced mid-gestation pregnancy terminations in rabbits.
    Özalp GR; Temizel EM; Özocak-Batmaz E
    J S Afr Vet Assoc; 2013 May; 84(1):E1-5. PubMed ID: 23718772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservative treatments for feline fibroadenomatous changes of the mammary gland.
    Marino G; Pugliese M; Pecchia F; Garufi G; Lupo V; Di Giorgio S; Sfacteria A
    Open Vet J; 2021; 11(4):680-685. PubMed ID: 35070864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of aglépristone, a progesterone receptor antagonist, administered during the early luteal phase in non-pregnant bitches.
    Galac S; Kooistra HS; Dieleman SJ; Cestnik V; Okkens AC
    Theriogenology; 2004 Aug; 62(3-4):494-500. PubMed ID: 15226005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone and ultrasonographic changes during aglepristone or cloprosternol treatment in queens at 21 to 22 or 35 to 38 days of pregnancy.
    García Mitacek MC; Bonaura MC; Praderio RG; Nuñez Favre R; de la Sota RL; Stornelli MA
    Theriogenology; 2017 Jan; 88():106-117. PubMed ID: 27865408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate.
    MacDougall LD
    Can Vet J; 2003 Mar; 44(3):227-9. PubMed ID: 12677692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is melatonin of value in cancer treatment? Experience with a case of feline mammary carcinoma.
    Baxter B
    Can Vet J; 2017 Jul; 58(7):750-752. PubMed ID: 28698696
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunohistochemical expression of progesterone receptors, growth hormone and insulin growth factor-I in feline fibroadenomatous change.
    Ordás J; Millán Y; de los Monteros AE; Reymundo C; de las Mulas JM
    Res Vet Sci; 2004 Jun; 76(3):227-33. PubMed ID: 15046957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of mastitis and abscessation of mammary glands secondary to fibroadenomatous hyperplasia in a primiparturient cat.
    Burstyn U
    J Am Vet Med Assoc; 2010 Feb; 236(3):326-9. PubMed ID: 20113246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, biological and hormonal study of mid-pregnancy termination in cats with aglepristone.
    Fieni F; Martal J; Marnet PG; Siliart B; Guittot F
    Theriogenology; 2006 Oct; 66(6-7):1721-8. PubMed ID: 16563487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammary adenocarcinomas in three male cats exposed to medroxyprogesterone acetate (1990-2006).
    Jacobs TM; Hoppe BR; Poehlmann CE; Ferracone JD; Sorenmo KU
    J Feline Med Surg; 2010 Feb; 12(2):169-74. PubMed ID: 19818661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy.
    Cunha SC; Corgozinho KB; Souza HJ; Silva KV; Ferreira AM
    J Feline Med Surg; 2015 Dec; 17(12):1000-4. PubMed ID: 25673018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoluteoidism in a dog associated with recurrent mammary fibroadenoma stimulated by progestin therapy.
    Zedda MT; Bogliolo L; Antuofermo E; Falchi L; Ariu F; Burrai GP; Pau S
    Acta Vet Scand; 2017 Sep; 59(1):55. PubMed ID: 28877731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of oral cyclosporin to treat feline dermatoses: a retrospective analysis of 23 cases.
    Vercelli A; Raviri G; Cornegliani L
    Vet Dermatol; 2006 Jun; 17(3):201-6. PubMed ID: 16674736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trilostane therapy for treatment of pituitary-dependent hyperadrenocorticism in 5 cats.
    Neiger R; Witt AL; Noble A; German AJ
    J Vet Intern Med; 2004; 18(2):160-4. PubMed ID: 15058766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of the use of aglepristone, with or without cloprostenol, to treat cystic endometrial hyperplasia-pyometra complex in bitches.
    Fieni F
    Theriogenology; 2006 Oct; 66(6-7):1550-6. PubMed ID: 16563489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects.
    Hayden DW; Johnston SD; Kiang DT; Johnson KH; Barnes DM
    Am J Vet Res; 1981 Oct; 42(10):1699-1703. PubMed ID: 7198885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elective caesarean operation in the bitch using aglepristone before the pre-partum decline in peripheral progesterone concentration.
    Levy X; Fontaine E; Segalini V; Fontbonne A
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():182-4. PubMed ID: 19754563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.